NARCOLEPSY
Clinical trials for NARCOLEPSY explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY trials appear
Sign up with your email to follow new studies for NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Narcolepsy drug trial cut short – early results show promise for daytime alertness
Symptom relief TerminatedThis early-stage study tested an experimental drug called MK-6552 in 9 people with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug could help them stay awake longer during the day and to check for side effects. The trial was stoppe…
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief
Last updated May 17, 2026 00:25 UTC
-
New narcolepsy drug shows promise in early trial
Symptom relief TerminatedThis early-stage study tested a new drug called JZP441 in 6 adults with narcolepsy type 1, a condition that causes sudden sleep attacks. The goal was to see if the drug helps people stay awake during the day and to check for side effects. The study was stopped early, but results …
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC